Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

ClinicalTrials.gov ID: NCT00032968

Public ClinicalTrials.gov record NCT00032968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Buprenorphine/Naloxone Versus Clonidine For Out-patient Opiate Detoxification

Study identification

NCT ID
NCT00032968
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of California, Los Angeles
Other
Enrollment
341 participants

Conditions and interventions

Interventions

  • Buprenorphine/naloxone Drug

Drug

Eligibility (public fields only)

Age range
15 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2000
Primary completion
Jul 31, 2002
Completion
Jul 31, 2002
Last update posted
Jan 11, 2017

2001 – 2002

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Haight-Ashbury Free Clinic Berkeley California 94704
Aegis Medical Systems, Inc. Oxnard California 93033
Midtown Community Mental Health Center Indianapolis Indiana 46202
UMDNJ - Robert Wood Johnson Medical School Piscataway New Jersey 08854
Addiction Research and Treatment Corp Brooklyn New York 11201
Bellevue New York New York 10016
Kaiser Permanente Northwest, Division of Addiction Portland Oregon 97227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00032968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00032968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →